Public Notices: Peak Powder River Resources, LLC (F031172/A0016113)
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
09/20/2024 | Press release | Distributed by Public on 09/20/2024 13:04
Please select the service you want to use:
Smartlinks | Bayridge Resources Corp. | Finance | Metals Markets | Security Markets | Commodities | Security Markets | Company News | Metals | Non-Ferrous Metals | Metals Markets | Precious Metals and Minerals Exploration and Processing Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | OTC Markets | Canadian Securities Exchange (CSE) | Tradegate Exchange | Cboe Canada | Omega ATS | Lynx ATS | Nasdaq CX2 | Nasdaq CXC
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact